Stay updated on Pembrolizumab + Lenvatinib in Advanced Melanoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab + Lenvatinib in Advanced Melanoma Clinical Trial page.

Latest updates to the Pembrolizumab + Lenvatinib in Advanced Melanoma Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedA new revision entry, v3.5.4, was added to the study record history. This indicates an update to the record that supersedes the previous v3.5.3 revision.SummaryDifference0.1%

- Check21 days agoNo Change Detected
- Check29 days agoNo Change Detected
- Check36 days agoChange DetectedRevision: v3.5.3 was added to the page, replacing the previous v3.5.2. This represents a small update to the page's version labeling in the Record History.SummaryDifference0.1%

- Check43 days agoChange DetectedThe page’s displayed revision/version number was updated from v3.5.0 to v3.5.2. This does not indicate any change to the underlying study information.SummaryDifference0.1%

- Check72 days agoChange DetectedThe history section shows Revision: v3.5.0 as the latest entry, replacing the previous Revision: v3.4.3.SummaryDifference0.1%

- Check86 days agoChange DetectedAdded revision entry: v3.4.3; removed revision: v3.4.2 from the history.SummaryDifference0.1%

- Check108 days agoChange DetectedRevision history updated: added v3.4.2 and removed v3.4.1.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab + Lenvatinib in Advanced Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab + Lenvatinib in Advanced Melanoma Clinical Trial page.